Brain HealthResearch PaperPaywall

Shared genetic factors link psychiatric and neurodegenerative disorders to specific brain structure differences

A genetic analysis of 16 brain disorders maps shared and distinct risk loci onto 3,935 brain imaging measures, including cortical thickness and volume.

Saturday, November 21, 2026 0 views
Published in Biol Psychiatry Cogn Neurosci Neuroimaging
A brain MRI scan displayed on a monitor in a radiology reading room, with a researcher viewing cortical slices

Summary

Psychiatric and neurodegenerative diseases share some symptoms, but why has been unclear. Researchers used large genetic datasets covering 12 psychiatric disorders and four neurodegenerative diseases and grouped them into five genetic factors: internalizing, addiction, schizophrenia/bipolar, neurodevelopmental, and Alzheimer's/ALS. They then linked 99 fine-mapped genetic variants to 3,935 brain imaging measures. The factors shared gene-expression enrichment in frontal and anterior cingulate cortex, while a few patterns were factor-specific. A variant in BANK1 tied to the addiction factor was associated with more than 400 imaging measures, and a variant in MOBP tied to the Alzheimer's/ALS factor with more than 200, many involving cortical thickness. This is a genetic-association study using population data, not a test in patients or an intervention. It points to brain regions and pathways worth studying, but does not show cause or offer treatment guidance.

Detailed Summary

Why this matters: Psychiatric and neurodegenerative conditions overlap in symptoms such as mood change, cognitive decline and social withdrawal, yet the brain biology behind both the overlap and the differences is poorly understood. Mapping shared genetic architecture onto brain structure may help explain why some brain changes in midlife raise the risk of later decline.

What was studied: The team used genome-wide association data for 12 psychiatric disorders and four neurodegenerative diseases. Genomic structural equation modeling grouped them into five latent genetic factors: internalizing (F1), addiction (F2), schizophrenia/bipolar (F3), neurodevelopmental (F4), and Alzheimer's disease/amyotrophic lateral sclerosis (F5). They assessed polygenic overlap, shared loci and genetic causal relationships between these factors and 3,935 brain imaging-derived phenotypes.

Key results: All five factors showed transcriptomic enrichment in frontal and anterior cingulate cortical regions. F1 showed specific depletion in the substantia nigra, and F3 specific enrichment in the nucleus accumbens. Fine-mapping identified 99 variants, including shared loci (VRK2, TSHZ3, TCF4) and factor-specific ones (DRD2 for F2, SCN2A for F3, FOXP2 for F4, TNIP1 for F5). Brain-wide analysis found 1,480 imaging associations at a false discovery rate below 0.05. BANK1 rs1813006 (F2) was linked to over 400 measures, mainly cortical area, grey-white contrast, thickness and volume. MOBP rs1768190 (F5) was linked to over 200, about half involving cortical thickness.

Implications: The findings offer a map of where genetic risk for different disorders converges on the brain, and which loci act broadly or narrowly. The MOBP result fits a role for myelin-related biology in neurodegeneration, and the shared frontal findings suggest common vulnerable circuits.

Caveats: This is a genetic-association study based on the abstract only. It reports mechanism-level association, not function or lifespan outcomes, and no intervention was tested. Associations do not establish cause, and results may not generalize across ancestries.

Key Findings

  • Genomic SEM grouped 16 disorders into five genetic factors: internalizing, addiction, schizophrenia/bipolar, neurodevelopmental, and Alzheimer's/ALS.
  • All five factors showed shared gene-expression enrichment in frontal and anterior cingulate cortex; substantia nigra and nucleus accumbens patterns were factor-specific.
  • Fine-mapping found 99 variants and 1,480 brain imaging associations at FDR q<0.05.
  • BANK1 rs1813006 (addiction factor) was associated with over 400 imaging measures, mostly cortical area, thickness and volume.
  • MOBP rs1768190 (Alzheimer's/ALS factor) was linked to over 200 imaging measures, about half involving cortical thickness.

Methodology

Genetic study using GWAS summary statistics for 12 psychiatric and four neurodegenerative disorders, combined with genomic structural equation modeling to derive five latent factors. Analyses covered polygenic overlap, transcriptomic enrichment, fine-mapping and genetic causal inference against 3,935 brain imaging-derived phenotypes, with FDR correction (q<0.05).

Study Limitations

Summary is based on the abstract only; sample sizes, ancestry composition and sensitivity analyses were not available. Genetic associations with imaging do not prove causation, and no intervention, function or lifespan outcomes were tested. The abstract itself describes some regional specificity as 'appeared' specific.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: